Andere talen Duopharma Biotech

Aandelen

DPHARMA

MYL7148OO009

slotkoers BURSA MALAYSIA Andere beurzen 00:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,26 ^MYR	+0,80%		+1,61%	0,00%

06/06	Duopharma Biotech Berhad benoemt Datuk Nik Moustpha Bin Haji Nik Hassan tot onafhankelijk en niet-leidinggevend lid van het Risicocomité, datum van wijziging 7 juni 2024	CI
06/06	Duopharma Biotech Berhad kondigt ontslag aan van Datin Paduka Kartini Binti Hj Abdul Manaf als onafhankelijk en niet-leidinggevend lid van de Risicocommissie, datum van wijziging 7 juni 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Duopharma Biotech Berhad Appoints Datuk Nik Moustpha Bin Haji Nik Hassan as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024	06/06
Duopharma Biotech Berhad Announces Resignation of Datin Paduka Kartini Binti Hj Abdul Manaf as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024	06/06
Duopharma Biotech Berhad Announces Retirement of Tan Sri, Datin Paduka Siti Sa'diah Binti Sh Bakir as Non-Independent and Non-Executive Chairman	06/06
Duopharma Biotech Berhad Appoints Puan Nik Fazila Binti Nik Mohamed Shihabuddin as Independent and Non-Executive Director, Date of Change 7 June 2024	06/06
Duopharma Biotech Berhad Announces Re-Designation of Datin Paduka Kartini Binti Hj Abdul Manaf, Independent Director as Non-Independent and Non-Executive Chairman, Date of Change 7 June 2024	06/06
Duopharma Biotech Berhad Appoints Puan Nik Fazila Binti Nik Mohamed Shihabuddin as Independent and Non-Executive Member of Audit Committee, Date of Change 7 June 2024	06/06
Duopharma Biotech Berhad Announces Resignation of Datuk Nik Moustpha Bin Haji Nik Hassan as Independent and Non-Executive Member of Audit Committee, Date of Change 7 June 2024	06/06
Duopharma’s Attributable Income Shrinks in Q1; Shares Down 2%	24/05
Duopharma Biotech Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Duopharma Biotech Clinches MYR578 million Supply Deals	01/05
Duopharma Biotech Berhad Announces the Appointment of Mohd Haris Bin Mohd Arshad as Non Independent and Non Executive Member of Nomination and Remuneration Committee	20/03
Duopharma Biotech Berhad Appoints Mohd Haris Bin Mohd Arshad as Non-Independent and Non-Executive Director	20/03
Duopharma Biotech Berhad Announces the Resignation of Amizar Binti Mizuar as Non Independent and Non Executive Member of Nomination and Remuneration Committee	20/03
Duopharma Biotech Berhad Announces the Resignation of Puan Amizar Binti Mizuar as Non Independent and Non Executive Director	20/03
Duopharma Biotech Berhad Announces the Cessation of Encik Muhammad Shukri Bin Ismail as Non Independent and Non Executive Alternate Director	20/03
Duopharma Biotech's Profit Plummets in Q4 2023	23/02
Duopharma Biotech Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Duopharma Biotech Berhad Announces Second Interim Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 21 March 2024	22/02
Duopharma Biotech Issues Further Islamic Debt Worth MYR29 Million	18/12
Duopharma Biotech Berhad Makes a Further Sukuk Wakalah Issuance of RMB 29.0 Million Under the Sukuk Wakalah Programme	15/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Duopharma Biotech

Aandelen

DPHARMA

MYL7148OO009

Andere talen

Filters